Mandate

VINGE ADVISES HEXATRONIC IN CONJUNCTION WITH RIGHTS ISSUE AND OVERSUBSCRIPTION OPTION

March 02, 2015

Vinge has advised Hexatronic Group AB (publ) listed on NASDAQ Stockholm First North in conjunction with a rights issue of approximately SEK 41 million with an oversubscription option of approximately SEK 10 million, which may be exercised if the rights issue is oversubscribed. One subscription right is provided for each share in Hexatronic and six subscription rights entitle the holder to subscribe for one new share. The subscription price amounts to SEK 9 per share. It is estimated that the rights issue prospectus will be published on or about 14 April 2015.

Vinge’s team consisted of responsible partner Anders Strid together with associates Frida Bäckegren, Daniel Lennartsson and corporate assistant Camilla Andersson.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026